Argiris Symeonidis

Also affiliated with General University Hospital of Patras, Patras Olympian Hospital

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Survival and quality of life in patients with lower risk myelodysplastic syndromes exposed to erythropoiesis-stimulating agents: an observational cohort study”.

Survival and quality of life in patients with lower risk myelodysplastic syndromes exposed to erythropoiesis-stimulating agents: an observational cohort study

The Lancet Haematology(2025)10.1016/s2352-3026(24)00350-8

N/A

0.373DataRank · unranked

5 citations

Timothy Bagguley, Adele Taylor, Pierre Fenaux, David Bowen, Argiris Symeonidis +18 more

Cardiac effects of deferasirox in transfusion‐dependent patients with myelodysplastic syndromes: TELESTO study

British Journal of Haematology(2024)10.1111/bjh.19316

N/A

0DataRank · unranked

6 citations

Junmin Li, Xiao Li, Depei Wu, Efreen Montaño Figueroa, Maria Guadalupe Rodriguez +15 more